NEW YORK, NY / ACCESS Newswire / February 20, 2025 / If you suffered a loss on your Pacira BioSciences, Inc. (NASDAQ:PCRX) investment and want to ...
PARSIPPANY, N.J., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the ...
If you purchased or acquired securities in Pacira between August 2, 2023 and August 8, 2024 and would like to discuss your ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results